Oncotelic Therapeutics, Inc.

OTC:OTLC

0.037 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992
Revenue 0.07001.7410-0-0000.0950.0950.1560000.0120.01200.0010.0070.030.3359.861.6951.2720.10.10.10.10.30.10.1
Cost of Revenue 00.0130.06200.0610.0340.0090.0190.0200000025.9422.27317.91613.04810.48001.5081.6151.256-0.1000000
Gross Profit 0.07-0.013-0.0621.741-0.061-0.034-0.009-0.019-0.020.0950.0950.156000-25.928-22.261-17.916-13.047-10.4730.030.3358.3520.080.0160.20.10.10.10.30.10.1
Gross Profit Ratio 10010342.899100111000-2,160.667-1,855.0830-13,047-1,496.143110.8470.0470.0132111111
Reseach & Development Expenses 0.0610.7573.6594.3021.3720.81510.4718.7649.0867.4083.6363.5235.29112.11422.25618.43414.1310.8167.0985.8493.9385.1036.1328.0588.39810.47.34.80000
General & Administrative Expenses 0.5744.8545.4675.0232.9392.1873.3714.9954.5965.2424.7394.695.3755.8858.97.5188.1557.15.9514.545.2827,438.2150000000000
Selling & Marketing Expenses 000000000000000000000-7,430.7770000000000
SG&A 0.5744.8545.4675.0232.9392.1873.3714.9954.5965.2424.7394.695.3755.8858.97.5188.1557.15.9514.545.2827.4385.4473.163.3363.131.84.13.12.11.6
Other Expenses 0.0720.533000-0.001-0.00500000.01500000000.0980.0980.0980.298-0.2310.0350.10.100000
Operating Expenses 0.6355.6119.1269.3264.3113.00213.84213.75913.68212.658.3758.21310.66617.99931.15625.95222.28517.91613.04910.4879.31812.63911.87710.98711.76913.610.46.64.13.12.11.6
Operating Income -0.565-9.722-9.126-7.585-4.311-3.002-13.842-13.759-13.682-12.65-8.28-8.072-11.892-18.509-31.156-25.94-22.273-17.916-13.048-10.48-9.288-12.305-3.525-10.907-11.753-13.4-10.3-6.5-4-2.8-2-1.5
Operating Income Ratio -8.0700-4.357030,020138,42000-133.158-87.158-51.744000-2,161.667-1,856.0830-13,048-1,497.143-309.6-36.783-0.358-6.435-9.24-134-103-65-40-9.333-20-15
Total Other Income Expenses Net -7.64114.398-1.391-2.387-2.3270.249-0.005-0.0010.0280.0030.003-0.0221.013-5.7710.0473.401-0.0712.4591.1390.4560.9561.344-0.5520022.20.70.4000
Income Before Tax -8.2064.677-10.517-9.972-6.638-2.737-13.812-13.654-13.654-12.647-8.277-8.079-10.879-24.28-28.943-22.539-22.344-15.457-11.909-10.024-8.332-10.961-4.07700-11.4-8.1-5.8-3.6000
Income Before Tax Ratio -117.2300-5.728027,370138,12000-133.126-87.126-51.788000-1,878.25-1,8620-11,909-1,432-277.733-32.765-0.41400-114-81-58-36000
Income Tax Expense -0.303-13.1430.8771.5290.75-0.265-0.03-0.105-0.028-0.003-0.0030.022-2.2395.261-6.428-4.539-1.884-2.459-1.139-0.456-0.92-1.2910.614-1.82-1.304-1.9-2.2-0.5-0.32.820.1
Net Income -7.90317.82-11.394-11.501-7.388-2.737-13.812-13.654-13.654-12.647-8.277-8.079-9.653-23.77-24.728-21.401-20.389-15.457-11.909-10.024-8.368-11.013-4.139-9.087-10.449-11.5-8.1-6-3.7-2.8-2-1.6
Net Income Ratio -112.90100-6.606027,370138,12000-133.126-87.126-51.788000-1,783.417-1,699.0830-11,909-1,432-278.933-32.923-0.42-5.362-8.215-115-81-60-37-9.333-20-16
EPS -0.020.046-0.038-0.13-0.12-0.074-0.52-0.51-0.54-0.75-2.95-5.48-10.37-71.6-111.11-167.56-175.2-134.28-145.35-145.28-152.33-211.22-88.04-195.06-244.09-271.28-198.94-193.56-151.2-134.4-120-108
EPS Diluted -0.020.039-0.038-0.13-0.12-0.074-0.52-0.51-0.54-0.75-2.95-5.48-10.37-71.6-111.11-167.56-175.2-134.28-145.35-145.28-152.33-211.22-88.04-195.06-244.09-271.28-198.94-193.56-151.2-134.4-120-108
EBITDA -0.565-5.064-9.064-7.221-4.25-3.25-13.833-13.739-13.69-12.653-8.283-8.035-11.679-12.228-31.203-29.11-21.989-20.189-14.045-10.811-9.668-13.405-2.675-11.138-11.718-15.3-12.4-7.2-4.4-2.8-2-1.5
EBITDA Ratio -8.0700-4.148032,500138,33000-133.189-87.189-51.506000-2,425.833-1,832.4170-14,045-1,544.429-322.267-40.073-0.271-6.571-9.213-153-124-72-44-9.333-20-15